Günes-Altan, Merve
Bosch, Agnes
Striepe, Kristina
Bramlage, Peter
Schiffer, Mario
Schmieder, Roland E.
Kannenkeril, Dennis
Funding for this research was provided by:
Universitätsklinikum Erlangen
Article History
Received: 29 December 2023
Accepted: 1 April 2024
First Online: 29 May 2024
Declarations
:
: Written informed consent was obtained from each patient before study inclusion. The study protocol was approved by the Local Ethics Committee (University of Erlangen- Nuremberg), and the studies were conducted in accordance with the Declaration of Helsinki and the principles of good clinical practice guidelines.
: All authors gave full consent for publication.
: MGA and other authors except RES declare that they have no conflict of interest with respect to this study. RES has conflict of interests with respect to this study: Boehringer Ingelheim, AstraZeneca (grants to the institution, speaker and adviser bureau).